Phase II study of erlotinib in metastatic or unresectable malignant peripheral nerve sheath tumors (MPNST)
Patients with pre-existing cardiovascular risk factors should be monitored appropriately when initiating tirzepatide therapy, particularly during dose escalation when gastrointestinal effects are most pronounced
HOW TO GET A GLP-1 RA One of the biggest challenges with GLP-1 RA is their cost and accessibility
Chen, C.-L., Wu, S.-T., Cha, T.-L., Sun, G.-H
Retatrutide will enter this exact same landscape
181,182 In the apoptosis pathway, Fas ligation changes its conformational structure, allowing signaling molecules (i.e., FADD, cFLIP, and procaspase-8) to bind to the intracellular C-terminal signaling death domain of the receptor